USPTO serial 90124014
NEW ENGLAND BIOLABS, INC. BE INSPIRED DRIVE DISCOVERY STAY GENUINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 1, 2022
- Examiner
- BERNS, LEE ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NEW ENGLAND BIOLABS, INC. BE INSPIRED DRIVE DISCOVERY STAY GENUINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for scientific research use; Reagents for molecular biology and cell biology for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Reagents for diagnostic tests and diagnostic devices for scientific or laboratory purposes, or for in vitro diagnostic processes, or for manufacture of biological reagents, or in vitro diagnostic purposes, all excluding medical or veterinary use; Reagents for genetic research, clinical or medical laboratory use; Reagents for detecting mutations for clinical or medical laboratory use; Reagents for transfer of nucleic acids into cells for laboratory use, research use, or diagnostic use, namely, diagnostic processes for manufacture of biological reagents not for medical or veterinary use; Nucleic acid amplification reagents for scientific, research, laboratory or in vitro diagnostic use; Nucleic acid sequencing reagents for scientific, research, laboratory or in vitro diagnostic use; RNA reverse transcription reagents for scientific, research, laboratory or in vitro diagnostic use; Nucleic acid cleavage reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid synthesis reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid ligation reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid cloning reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid fragment assembly reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid binding reagents for scientific, research, laboratory or in vitro diagnostic use; Nucleic acid purification substrates for scientific, research, laboratory or in vitro diagnostic use; Genome editing reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Glycobiology reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Buffer reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acids for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Oligonucleotides for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleotides for scientific, research, laboratory or in vitro diagnostic use; Cells for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Molecular tags for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Dyes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Magnetic beads comprised primarily of iron oxides, for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; DNA Adapters for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid purification substrates for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Storage reagents being reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; DNA molecular weight markers; Plasmids for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Molecular size markers for use in molecular biology for determining the size of molecules for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Cells for use in molecular biology for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Prokaryotic cells for cloning for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Enzyme reagents for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Enzymes for scientific and research use; Enzymes for diagnostic use, namely, enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Enzymes for molecular biology and cell biology applications, namely, for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Chemicals and biochemicals in the nature of enzymes for the manufacture of vaccines and pharmaceuticals; Kits for scientific and research use comprising enzymes; Kits for in vitro diagnostic use comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid cloning kits comprising a cloning enzyme or plasmid for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid amplification kits comprising an amplification enzyme for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid sequencing kits comprising a sequencing enzyme for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; RNA reverse transcription kits comprising a reverse transcriptase for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid cleavage kits comprising cleavage enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use, not for medical or veterinary use; Nucleic acid synthesis kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid ligation kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid cloning kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Genome editing kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid fragment assembly kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Nucleic acid binding kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Glycobiology kits comprising enzymes for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use; Kits containing buffer reagents, nucleic acids, nucleotides, cells, molecular tags, dyes, nucleic acid purification substrates, enzymes, storage reagents, DNA molecular weight markers, and DNA plasmids for scientific, research, laboratory or in vitro diagnostic use, not for medical or veterinary use | ACTIVE | Dec 31, 2016 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by New England Biolabs, Inc.
- Other trademarks owned by New England Biolabs, Inc.
- Other trademarks owned by New England Biolabs, Inc.
- Other trademarks in Class 001
- Similar marks named NEW ENGLAND BIOLABS, INC. BE INSPIRED DRIVE DISCOVERY STAY GENUINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 4, 2023 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Mar 1, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 14, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 14, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 24, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 7, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 7, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 7, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 7, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 7, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 7, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 7, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 7, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 4, 2021 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 4, 2021 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 4, 2021 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Sep 23, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 23, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 23, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 23, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 26, 2021 | PCGR | PETITION TO DIRECTOR GRANTED | — |
| Aug 12, 2021 | APET | ASSIGNED TO PETITION STAFF | — |
| Apr 15, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Apr 15, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Apr 15, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Apr 8, 2021 | TPDR | TEAS PETITION TO DIRECTOR RECEIVED | — |
| Mar 15, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 15, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 24, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 24, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 22, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 2020 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 20, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 22, 2020 | NWAP | NEW APPLICATION ENTERED | — |